(Q39244812)

2 July 2019

title

Metabolic reprograming of anti-tumor immunity (English)

1 reference

2 July 2019

author

Nicholas P. Restifo

series ordinal

3

1 reference

2 July 2019

author name string

Madhusudhanan Sukumar

series ordinal

1

1 reference

2 July 2019

Rigel J Kishton

series ordinal

2

1 reference

2 July 2019

publication date

13 April 2017

1 reference

2 July 2019

Current Opinion in Immunology

published in

1 reference

2 July 2019

volume

46

1 reference

2 July 2019

page(s)

14-22

1 reference

2 July 2019

Second and subsequent lines of chemotherapy for metastatic breast cancer: what did we learn in the last two decades?

cites work

1 reference

12 December 2020

Is HIF-1alpha a pro- or an anti-apoptotic protein?

1 reference

12 December 2020

Hypoxia-inducible factor regulates survival of antigen receptor-driven T cells

1 reference

12 December 2020

Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells

1 reference

12 December 2020

Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells

1 reference

12 December 2020

Memory T and memory B cells share a transcriptional program of self-renewal with long-term hematopoietic stem cells

1 reference

12 December 2020

Metastasis: a question of life or death

1 reference

12 December 2020

FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress

1 reference

12 December 2020

Tumor-specific Th17-polarized cells eradicate large established melanoma

1 reference

12 December 2020

Adoptive cell transfer: a clinical path to effective cancer immunotherapy

1 reference

12 December 2020

Enhancing CD8 T-cell memory by modulating fatty acid metabolism

1 reference

12 December 2020

Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cells

1 reference

12 December 2020

mTOR regulates memory CD8 T-cell differentiation

1 reference

12 December 2020

The mTOR kinase determines effector versus memory CD8+ T cell fate by regulating the expression of transcription factors T-bet and Eomesodermin

1 reference

12 December 2020

Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1

1 reference

12 December 2020

Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets.

1 reference

12 December 2020

Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy

1 reference

12 December 2020

The tumor suppressor Tsc1 enforces quiescence of naive T cells to promote immune homeostasis and function

1 reference

12 December 2020

A human memory T cell subset with stem cell-like properties

1 reference

12 December 2020

An interleukin-21-interleukin-10-STAT3 pathway is critical for functional maturation of memory CD8+ T cells

1 reference

12 December 2020

B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells

1 reference

12 December 2020

The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation

1 reference

12 December 2020

Mitochondrial respiratory capacity is a critical regulator of CD8+ T cell memory development

1 reference

12 December 2020

Cellular constituents of immune escape within the tumor microenvironment

1 reference

12 December 2020

Mitochondria are required for antigen-specific T cell activation through reactive oxygen species signaling.

1 reference

12 December 2020

Chimeric antigen receptor-modified T cells for acute lymphoid leukemia

1 reference

12 December 2020

Posttranscriptional control of T cell effector function by aerobic glycolysis

1 reference

12 December 2020

Hypoxia-inducible factors enhance the effector responses of CD8(+) T cells to persistent antigen.

1 reference

12 December 2020

Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function.

1 reference

12 December 2020

The short and sweet of T-cell therapy: Restraining glycolysis enhances the formation of immunological memory and antitumor immune responses

1 reference

12 December 2020

The glucose transporter Glut1 is selectively essential for CD4 T cell activation and effector function

1 reference

12 December 2020

Drug resistance to molecular targeted therapy and its consequences for treatment decisions in non-small-cell lung cancer

1 reference

12 December 2020

Tsc1 promotes the differentiation of memory CD8+ T cells via orchestrating the transcriptional and metabolic programs

1 reference

12 December 2020

Akt inhibition enhances expansion of potent tumor-specific lymphocytes with memory cell characteristics.

1 reference

12 December 2020

Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation

1 reference

12 December 2020

Mitochondria in the regulation of innate and adaptive immunity

1 reference

12 December 2020

PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation

1 reference

12 December 2020

The future of immune checkpoint therapy

1 reference

12 December 2020

Adoptive cell transfer as personalized immunotherapy for human cancer

1 reference

12 December 2020

mTORC1 and mTORC2 selectively regulate CD8⁺ T cell differentiation

1 reference

12 December 2020

Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses.

1 reference

12 December 2020

Cancer mediates effector T cell dysfunction by targeting microRNAs and EZH2 via glycolysis restriction.

1 reference

12 December 2020

Mitochondrial Membrane Potential Identifies Cells with Enhanced Stemness for Cellular Therapy.

1 reference

12 December 2020

Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T Cells

1 reference

12 December 2020

Modulation of mTOR Signalling Triggers the Formation of Stem Cell-like Memory T Cells

1 reference

12 December 2020

Potentiating the antitumour response of CD8(+) T cells by modulating cholesterol metabolism

1 reference

12 December 2020

Emerging concepts of T cell metabolism as a target of immunotherapy.

1 reference

12 December 2020

Asymmetric inheritance of mTORC1 kinase activity during division dictates CD8(+) T cell differentiation

1 reference

12 December 2020

Metabolic maintenance of cell asymmetry following division in activated T lymphocytes

1 reference

12 December 2020

Mitochondrial Dynamics Controls T Cell Fate through Metabolic Programming.

1 reference

12 December 2020

A guide to immunometabolism for immunologists.

1 reference

12 December 2020

Bioenergetic Insufficiencies Due to Metabolic Alterations Regulated by the Inhibitory Receptor PD-1 Are an Early Driver of CD8(+) T Cell Exhaustion

1 reference

12 December 2020

The Tumor Microenvironment Represses T Cell Mitochondrial Biogenesis to Drive Intratumoral T Cell Metabolic Insufficiency and Dysfunction

1 reference

12 December 2020

Oxygen Sensing by T Cells Establishes an Immunologically Tolerant Metastatic Niche.

1 reference

12 December 2020

Ionic immune suppression within the tumour microenvironment limits T cell effector function.

1 reference

12 December 2020

Aerobic glycolysis promotes T helper 1 cell differentiation through an epigenetic mechanism

1 reference

12 December 2020

Specification of haematopoietic stem cell fate via modulation of mitochondrial activity

1 reference

12 December 2020

L-Arginine Modulates T Cell Metabolism and Enhances Survival and Anti-tumor Activity

1 reference

12 December 2020

Constitutive Glycolytic Metabolism Supports CD8(+) T Cell Effector Memory Differentiation during Viral Infection.

1 reference

12 December 2020

T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer.

1 reference

12 December 2020

Oxidative status predicts quality in human mesenchymal stem cells

1 reference

12 December 2020

10.1016/J.COI.2017.03.011

Identifiers

DOI

1 reference

2 July 2019

release_7vtt5pelebgpxezye2zdudc7hq

Fatcat ID

0 references

PMC publication ID

6327315

1 reference

2 July 2019

PubMed publication ID

28412583

1 reference

2 July 2019